Robinson Emma Louise, Gomes Clarissa Pedrosa da Costa, Potočnjak Ines, Hellemans Jan, Betsou Fay, de Gonzalo-Calvo David, Stoll Monika, Yilmaz Mehmet Birhan, Ágg Bence, Beis Dimitris, Carmo-Fonseca Maria, Enguita Francisco J, Dogan Soner, Tuna Bilge G, Schroen Blanche, Ammerlaan Wim, Kuster Gabriela M, Carpusca Irina, Pedrazzini Thierry, Emanueli Costanza, Martelli Fabio, Devaux Yvan
Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, 6229 ER Maastricht, The Netherlands.
Cardiovascular Research Unit, Luxembourg Institute of Health, L-1445 Strassen, Luxembourg.
Noncoding RNA. 2020 May 18;6(2):17. doi: 10.3390/ncrna6020017.
The EU-CardioRNA Cooperation in Science and Technology (COST) Action is a European-wide consortium established in 2018 with 31 European country members and four associate member countries to build bridges between translational researchers from academia and industry who conduct research on non-coding RNAs, cardiovascular diseases and similar research areas. EU-CardioRNA comprises four core working groups (WG1-4). In the first year since its launch, EU-CardioRNA met biannually to exchange and discuss recent findings in related fields of scientific research, with scientific sessions broadly divided up according to WG. These meetings are also an opportunity to establish interdisciplinary discussion groups, brainstorm ideas and make plans to apply for joint research grants and conduct other scientific activities, including knowledge transfer. Following its launch in Brussels in 2018, three WG meetings have taken place. The first of these in Lisbon, Portugal, the second in Istanbul, Turkey, and the most recent in Maastricht, The Netherlands. Each meeting includes a scientific session from each WG. This meeting report briefly describes the highlights and key take-home messages from each WG session in this first successful year of the EU-CardioRNA COST Action.
欧盟心血管RNA科技合作行动（COST行动）是一个于2018年成立的全欧洲联盟，有31个欧洲成员国和4个准成员国，旨在搭建学术和产业界转化研究人员之间的桥梁，这些研究人员从事非编码RNA、心血管疾病及类似研究领域的研究。欧盟心血管RNA合作行动包括四个核心工作组（WG1 - 4）。自启动后的第一年，欧盟心血管RNA合作行动每半年举行一次会议，以交流和讨论相关科研领域的最新发现，科学会议大致按工作组划分。这些会议也是建立跨学科讨论小组、集思广益并制定申请联合研究资助计划以及开展包括知识转移在内的其他科学活动的契机。2018年在布鲁塞尔启动后，已举行了三次工作组会议。第一次在葡萄牙里斯本，第二次在土耳其伊斯坦布尔，最近一次在荷兰马斯特里赫特。每次会议都包括每个工作组的科学会议环节。本会议报告简要介绍了在欧盟心血管RNA合作行动成功开展的第一年里，每个工作组会议环节的亮点和关键要点。
